Literature DB >> 10580808

Cytokine regulation of CD40 expression in fetal human astrocyte cultures.

N Abdel-Haq1, H N Hao, W D Lyman.   

Abstract

CD40 can participate in inflammatory processes after binding its cognate ligand (CD40L). We found that fetal human astrocytes constitutively express CD40 mRNA and protein. Upon incubating cultures with proinflammatory cytokines (TNF-alpha, IL-1beta and IFN-gamma) or with lipopolysaccharide (LPS), CD40 expression was increased. No change in CD40 expression was noted in astrocyte cultures incubated with IL-6, HIV or gp41. Astrocytes also showed increased release of proinflammatory cytokines TNF-alpha, IL-1beta and IL-6 after incubation with CD40L peptide. These observations suggest a role for CD40 in central nervous system (CNS) inflammation and that CD40/CD40L autocrine or paracrine pathways may mediate this role.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580808     DOI: 10.1016/s0165-5728(99)00124-1

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

Review 1.  Impact of the CD40-CD40L dyad in Alzheimer's disease.

Authors:  Brian Giunta; Kavon Rezai-Zadeh; Jun Tan
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-04       Impact factor: 4.388

2.  CD40 Negatively Regulates ATP-TLR4-Activated Inflammasome in Microglia.

Authors:  Sagar Gaikwad; Divyesh Patel; Reena Agrawal-Rajput
Journal:  Cell Mol Neurobiol       Date:  2016-03-10       Impact factor: 5.046

3.  CD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis.

Authors:  Teresa G D'Aversa; Karen M Weidenheim; Joan W Berman
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 4.  The role of antigen presenting cells in multiple sclerosis.

Authors:  Emily M L Chastain; D'Anne S Duncan; Jane M Rodgers; Stephen D Miller
Journal:  Biochim Biophys Acta       Date:  2010-07-15

5.  SOLUBLE CD40 LIGAND IN DEMENTIA.

Authors:  B Giunta; K P Figueroa; T Town; J Tan
Journal:  Drugs Future       Date:  2009-04-01       Impact factor: 0.148

Review 6.  Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

Authors:  Kavon Rezai-Zadeh; David Gate; Christine A Szekely; Terrence Town
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

7.  Rapid disease development in scrapie-infected mice deficient for CD40 ligand.

Authors:  Michael Burwinkel; Anja Schwarz; Constanze Riemer; Julia Schultz; Frank van Landeghem; Michael Baier
Journal:  EMBO Rep       Date:  2004-04-08       Impact factor: 8.807

Review 8.  Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.

Authors:  Lidia M Yshii; Reinhard Hohlfeld; Roland S Liblau
Journal:  Nat Rev Neurol       Date:  2017-11-06       Impact factor: 42.937

9.  CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models.

Authors:  Vincent Laporte; Ghania Ait-Ghezala; Claude-Henry Volmar; Michael Mullan
Journal:  J Neuroinflammation       Date:  2006-02-24       Impact factor: 8.322

10.  Regulation of chemokine CCL5 synthesis in human peritoneal fibroblasts: a key role of IFN-γ.

Authors:  Edyta Kawka; Janusz Witowski; Nina Fouqet; Hironori Tayama; Thorsten O Bender; Rusan Catar; Duska Dragun; Achim Jörres
Journal:  Mediators Inflamm       Date:  2014-01-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.